Cost analysis of hospitalized clostridium difficile-associated diarrhea (CDAD);Kostenanalyse der stationär behandelten Clostridium-difficile- assoziierten Diarrhö (CDAD)

Gesundheitsokonomie und Qualitatsmanagement

Volumn 18, Issue 2, 2013, Pages 80-85

  Hubner C ^a   Hubner N O ^b,c   Muhr, M ^a   Claus, F ^a   Leesch, H ^b   Kramer, A ^b   Flessa S ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

clostridium difficile; cost analysis; length of stay; nosocomial infections; opportunity costs

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; HYGIENE; LABORATORY TEST; LENGTH OF STAY; RETROSPECTIVE STUDY;

EID: 84876131264     PISSN: 14322625     EISSN: 14394049     Source Type: Journal    
DOI: 10.1055/s-0032-1330635     Document Type: Article

References (16)

1. Dubberke E. R., Wertheimer A. I. Review of current literature on the economic burden of Clostridium difficile infection. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America: 2009; 30 57 66 10.1086/592981
2. Kuijper E. J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases: 2006; 12 06 2 18 10.1111/j.1469-0691.2006. 01580.x (Pubitemid 44362038)
3. Kyne L., Hamel M. B., Polavaram R. et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America: 2002; 34 346 353 10.1086/338260 (Pubitemid 34062235)
4. Haley R. W. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. The American journal of medicine: 1991; 91 32S 38S
5. Al-Eidan F. A., McElnay J. C., Scott M. G. et al. Clostridium difficile-associated diarrhoea in hospitalised patients. Journal of clinical pharmacy and therapeutics: 2000; 25 101 109 (Pubitemid 30326409)
6. Vonberg R. P., Reichardt C., Behnke M. et al. Costs of nosocomial Clostridium difficile-associated diarrhoea. The Journal of hospital infection: 2008; 70 15 20 10.1016/j.jhin.2008.05.004
7. Wilcox M. H., Cunniffe J. G., Trundle C. et al. Financial burden of hospital-acquired Clostridium difficile infection. The Journal of hospital infection: 1996; 34 23 30 (Pubitemid 26313206)
8. McGlone S. M., Bailey R. R., Zimmer S. M. et al. The economic burden of Clostridium difficile. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases: 2012; 18 282 289 10.1111/j.1469-0691.2011.03571.x
9. KBV Einheitlicher Bewertungsmaßstab für ärztliche Leistungen. Kassenärztliche Bundesvereinigung: 2010
10. Graves N. Economics and preventing hospital-acquired infection. Emerging infectious diseases: 2004; 10 561 566 (Pubitemid 38420284)
11. Haubrock M. Krankenhausfinanzwirtschaft. In: Haubrook M., Schär W. (Hrsg.). Betriebswirtschaft und Management im Krankenhaus. 4. Aufl Bern Verlag Hans Huber: 2007; 394 453
12. InEK Fallpauschalenkatalog. Institut für das Entgeltsystem im Krankenhaus. G-DRG-Version: 2010
13. RKI Empfehlungen des Robert Koch- Institutes zu Hygienemaßnahmen bei Patienten mit Durchfällen aufgrund von toxinbildendem Clostridium difficile. aktualisiert: Dezember 2008.
14. Wiegand P. N., Nathwani D., Wilcox M. H. et al. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. The Journal of hospital infection: 2012; 81 1 14 10.1016/j.jhin.2012.02.004
15. Dubberke E. R., Reske K. A., Olsen M. A. et al. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America: 2008; 46 497 504 10.1086/526530 (Pubitemid 351263485)
16. Butterworth S. A., Koppert E., Clarke A. et al. Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility. American journal of surgery: 1998; 175 403 407 10.1016/S0002-9610(98)00058-0 (Pubitemid 28213455)